KH-656

N/A

Report date: 2025/06/11 10:50:19

Base Information

Drug NameKH-656
Drug Alias NameTNF-alpha gene therapy (Chengdu Origen Biotechnology)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionTumor necrosis factor modulators
TargetsTumor necrosis factor
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChengdu Origen Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Origen Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A